The opioid crisis in the United States has led to increased HCV infection among younger populations of people who inject drugs (PWID) and other vulnerable populations, who often seek care at community health centers. Recent evidence suggests that health center patients benefit from receiving hepatitis C virus (HCV) screening outside of the CDC recommendations of risk-factors and patients born between 1945 and 1965, referred to as the “baby boomer” birth cohort. Early treatment for HCV can lead to decreased transmission rates and increased cure rates with advances in oral medications.
This NNCC Learning Collaborative will walk participants through the steps to onboard a universal HCV screening program for patients 18 and older, while providing onsite treatment and behavioral health services. It will also provide tools to critically assess the costs and benefits associated with enhanced, comprehensive care. Dr. Michael Halpern, Associate Professor at the Temple University College of Public Health, will discuss the HCV cost-benefit calculator developed with Public Health Management Corporation and NNCC to evaluate results from universal screening and enhanced care at health centers in Philadelphia, Pennsylvania.
Part 1: HCV Programming in Community Health Centers
March 5, 2019 at 2:00 pm ET
Part 2: HCV Care Team Formation and Linkage to Care
March 19, 2019 at 2:00 ET
Part 3: Health Economics 101: Comparing Standard v. Enhanced HCV Screening and Treatment
April 02, 2019 at 2:00 ET
Part 4: Utilizing the HCV Cost Benefit Calculator to Evaluate Resources
April 16, 2019 at 2:00 ET
This learning collaborative training is pending for up to 4.0 prescribed credit hours by the American Academy of Family Physicians. The American Nurses Credentialing Center (ANCC) accepts AAFP CME toward it member continuing education requirements. Participants are eligible to receive one (1) CME/CNE credit per module. Up to four (4) credits are available.